Causal associations between inflammatory bowel disease and primary biliary cholangitis: a two-sample bidirectional Mendelian randomization study

[1]  E. Kotsiliti.  Phage therapy suppresses gut inflammation in IBD , 2022, Nature Biotechnology.

[2]  H. Tilg,et al.  The metabolic nature of inflammatory bowel diseases , 2022, Nature Reviews Gastroenterology & Hepatology.

[3]  Weixun Zhou,et al.  Autoimmune enteropathy and primary biliary cholangitis after proctocolectomy for ulcerative colitis: A case report and review of the literature , 2021, World journal of gastroenterology.

[4]  A. Tanaka.  Current understanding of primary biliary cholangitis , 2020, Clinical and molecular hepatology.

[5]  A. Bernabé-Ortiz,et al.  A systematic review of population-based studies on lipid profiles in Latin America and the Caribbean , 2020, eLife.

[6]  G. Macedo,et al.  Primary biliary cholangitis in patients with inflammatory bowel disease. , 2020, Clinics and research in hepatology and gastroenterology.

[7]  W. Kim,et al.  Diagnosis and Management of Primary Biliary Cholangitis , 2019, The American Journal of Gastroenterology.

[8]  Valeriia Haberland,et al.  The MR-Base platform supports systematic causal inference across the human phenome , 2018, eLife.

[9]  Nima Hamidi,et al.  Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies , 2017, The Lancet.

[10]  G. Macedo,et al.  Looking into Enteric Virome in Patients with IBD: Defining Guilty or Innocence? , 2017, Inflammatory bowel diseases.

[11]  S. Kamphuis,et al.  European evidence-based recommendations for diagnosis and treatment of childhood-onset systemic lupus erythematosus: the SHARE initiative , 2017, Annals of the rheumatic diseases.

[12]  S. Thompson,et al.  Interpreting findings from Mendelian randomization using the MR-Egger method , 2017, European Journal of Epidemiology.

[13]  S. Ng,et al.  The Worldwide Incidence and Prevalence of Inflammatory Bowel Disease in the 21 st Century: A Systematic Review of Population-Based Studies , 2017 .

[14]  M. Carbone,et al.  The "gut microbiota" hypothesis in primary sclerosing cholangitis. , 2016, Annals of translational medicine.

[15]  K. Koike,et al.  Changing nomenclature for PBC from “primary biliary cirrhosis” to “primary biliary cholangitis” , 2016, Hepatology research : the official journal of the Japan Society of Hepatology.

[16]  K. Koike,et al.  Changing Nomenclature for PBC from “Primary Biliary Cirrhosis” to “Primary Biliary Cholangitis” , 2016, Journal of Gastroenterology.

[17]  G. Davey Smith,et al.  Consistent Estimation in Mendelian Randomization with Some Invalid Instruments Using a Weighted Median Estimator , 2016, Genetic epidemiology.

[18]  H. Tilg,et al.  The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease. , 2016, Journal of Crohn's & colitis.

[19]  M. Carbone,et al.  Geoepidemiology, Genetic and Environmental Risk Factors for PBC , 2015, Digestive Diseases.

[20]  Judy H. Cho,et al.  Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations , 2015, Nature Genetics.

[21]  A. Floreani,et al.  Extrahepatic Autoimmune Conditions Associated with Primary Biliary Cirrhosis , 2015, Clinical Reviews in Allergy & Immunology.

[22]  G. Davey Smith,et al.  Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression , 2015, International journal of epidemiology.

[23]  A. Burroughs,et al.  Levels of alkaline phosphatase and bilirubin are surrogate end points of outcomes of patients with primary biliary cirrhosis: an international follow-up study. , 2014, Gastroenterology.

[24]  J. Colombel.  Decade in review—IBD: IBD—genes, bacteria and new therapeutic strategies , 2014, Nature Reviews Gastroenterology &Hepatology.

[25]  A. Ford,et al.  Systematic review: the epidemiology of the hepatobiliary manifestations in patients with inflammatory bowel disease , 2014, Alimentary pharmacology & therapeutics.

[26]  A. Butterworth,et al.  Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized Data , 2013, Genetic epidemiology.

[27]  O. James,et al.  Case–control studies of risk factors for primary biliary cirrhosis in two United Kingdom populations , 2010, Gut.

[28]  M. Seldin,et al.  Human leukocyte antigen polymorphisms in italian primary biliary cirrhosis: A multicenter study of 664 patients and 1992 healthy controls , 2008, Hepatology.

[29]  Y. Chrétien,et al.  Biochemical response to ursodeoxycholic acid and long‐term prognosis in primary biliary cirrhosis , 2008, Hepatology.

[30]  George Davey Smith,et al.  Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology , 2008, Statistics in medicine.

[31]  M. Kaplan,et al.  Risk factors and comorbidities in primary biliary cirrhosis: A controlled interview‐based study of 1032 patients , 2005, Hepatology.

[32]  D. Larrey.  Epidemiology and Individual Susceptibility to Adverse Drug Reactions Affecting the Liver , 2002, Seminars in liver disease.

[33]  E. Gold,et al.  Risk factors for primary biliary cirrhosis in a cohort of patients from the United States , 2001, Hepatology.

[34]  C. Benz,et al.  [Primary sclerosing cholangitis]. , 2000, Der Internist.

[35]  M. Tzardi,et al.  Ulcerative Colitis Associated with Primary Biliary Cirrhosis , 1999, Digestive Diseases and Sciences.

[36]  E. Petinaki,et al.  Association between ulcerative colitis and systemic lupus erythematosus: report of two cases , 1998, European journal of gastroenterology & hepatology.

[37]  T. Hibi,et al.  Circulating antibodies to the surface antigens on colon epithelial cells in ulcerative colitis. , 1983, Clinical and experimental immunology.

[38]  K. Hongo,et al.  A case report and review of the literature , 2006, Journal of Neuro-Oncology.

[39]  K. Lindor,et al.  Primary biliary cirrhosis , 1998, Springer Netherlands.

[40]  John H. Jopson,et al.  A REPORT OF TWO CASES , 1902 .